Harvard Health Letter

New hope for people with migraine headaches

Scientists are testing a new class of drugs to treat migraine headaches. The drugs would block (inhibit) a brain protein called CGRP that sends pain messages to the body.

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In